Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Peters

Showing results (131-140 of 168) with videos related to

Pageof 17
Sort By:
BMJ Open|August 24, 2024
Randomised controlled decentralised feasibility trial of a fixed low-dose combination antihypertensive drug strategy to attenuate cognitive decline in high-risk adultsCheryl Carcel, Lauren Clancy, Katie Harris, et al.
Age and Ageing|February 25, 2026
Association of frailty with dementia and the impact of frailty on antihypertensive treatment protection against dementia in older hypertensive adultsLinan Chen, Shoujiang You, Nicole Ee, et al.
Archives of Gerontology and Geriatrics|February 10, 2021
Intergenerational Programmes bringing together community dwelling non-familial older adults and children: A Systematic ReviewRuth Peters, Nicole Ee, Stephanie A Ward, et al.
The New England Journal of Medicine|April 2, 2008
Treatment of hypertension in patients 80 years of age or olderNigel S Beckett, Ruth Peters, Astrid E Fletcher, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 2, 2021
The epidemiology is promising, but the trial evidence is weak. Why pharmacological dementia risk reduction trials haven't lived up to expectations, and where do we go from here?Ruth Peters, Hiroko H Dodge, Sarah James, et al.
Journal of Alzheimer'S Disease : JAD|September 14, 2020
Future Directions for Dementia Risk Reduction and Prevention Research: An International Research Network on Dementia Prevention ConsensusKaarin J Anstey, Ruth Peters, Lidan Zheng, et al.
Journal of Cachexia, Sarcopenia and Muscle|March 19, 2026
Frailty and Recurrent Cardiovascular Events in Patients With Obstructive Sleep Apnoea: The SAVE StudyShoujiang You, Danni Zheng, Katie Harris, et al.
Dementia and Geriatric Cognitive Disorders|October 26, 2021
Evaluation of High Cholesterol and Risk of Dementia and Cognitive Decline in Older Adults Using Individual Patient Meta-AnalysisRuth Peters, Ying Xu, Riitta Antikainen, et al.
Cerebral Circulation - Cognition and Behavior|January 15, 2025
Cumulative blood pressure load and cognitive decline in older adults: An observational analysis of two large cohortsYing Xu, G Peggy McFall, Lina Rydén, et al.
BMJ Open|April 14, 2025
STatin TReatment for COVID-19 to Optimise NeuroloGical recovERy (STRONGER): study protocol for a randomised, open label clinical trial in patients with persistent neurological symptoms after COVID-19 infectionCarlos Delfino, Cheryl Carcel, Xiaolei Lin, et al.
Pageof 17

Showing results (131-140 of 168) with videos related to

Sort By:
Pageof 17
BMJ Open|August 24, 2024
Randomised controlled decentralised feasibility trial of a fixed low-dose combination antihypertensive drug strategy to attenuate cognitive decline in high-risk adultsCheryl Carcel, Lauren Clancy, Katie Harris, et al.
Age and Ageing|February 25, 2026
Association of frailty with dementia and the impact of frailty on antihypertensive treatment protection against dementia in older hypertensive adultsLinan Chen, Shoujiang You, Nicole Ee, et al.
Archives of Gerontology and Geriatrics|February 10, 2021
Intergenerational Programmes bringing together community dwelling non-familial older adults and children: A Systematic ReviewRuth Peters, Nicole Ee, Stephanie A Ward, et al.
The New England Journal of Medicine|April 2, 2008
Treatment of hypertension in patients 80 years of age or olderNigel S Beckett, Ruth Peters, Astrid E Fletcher, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 2, 2021
The epidemiology is promising, but the trial evidence is weak. Why pharmacological dementia risk reduction trials haven't lived up to expectations, and where do we go from here?Ruth Peters, Hiroko H Dodge, Sarah James, et al.
Journal of Alzheimer'S Disease : JAD|September 14, 2020
Future Directions for Dementia Risk Reduction and Prevention Research: An International Research Network on Dementia Prevention ConsensusKaarin J Anstey, Ruth Peters, Lidan Zheng, et al.
Journal of Cachexia, Sarcopenia and Muscle|March 19, 2026
Frailty and Recurrent Cardiovascular Events in Patients With Obstructive Sleep Apnoea: The SAVE StudyShoujiang You, Danni Zheng, Katie Harris, et al.
Dementia and Geriatric Cognitive Disorders|October 26, 2021
Evaluation of High Cholesterol and Risk of Dementia and Cognitive Decline in Older Adults Using Individual Patient Meta-AnalysisRuth Peters, Ying Xu, Riitta Antikainen, et al.
Cerebral Circulation - Cognition and Behavior|January 15, 2025
Cumulative blood pressure load and cognitive decline in older adults: An observational analysis of two large cohortsYing Xu, G Peggy McFall, Lina Rydén, et al.
BMJ Open|April 14, 2025
STatin TReatment for COVID-19 to Optimise NeuroloGical recovERy (STRONGER): study protocol for a randomised, open label clinical trial in patients with persistent neurological symptoms after COVID-19 infectionCarlos Delfino, Cheryl Carcel, Xiaolei Lin, et al.
Pageof 17